|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Startup and transition costs | |||||
| Cost of goods sold | |||||
| Continuing Operations | |||||
| Total cost of goods sold | |||||
| Gross profit (loss) | |||||
| General and administrative expenses | |||||
| Loss on sale of assets and asset impairments | |||||
| Continuing Operations | |||||
| Total loss on sale of assets and asset impairments | |||||
| Restructuring charges, net | |||||
| Loss from continuing operations | |||||
| Other income (expense): | |||||
| Interest expense, net | |||||
| Foreign currency loss | |||||
| Miscellaneous income | |||||
| Total other expense | |||||
| Reorganization items, net | |||||
| Loss from debtor operations before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Net loss from continuing operations | |||||
| Preferred stock dividends and accretion | |||||
| Gain on extinguishment of Series A Preferred Stock | |||||
| Series A Redeemable Preferred Stock | |||||
| Total gain on extinguishment of Series A Preferred Stock | |||||
| Net loss from continuing operations attributable to common stockholders | |||||
| Net loss from discontinued operations | |||||
| Net loss attributable to common stockholders | |||||
| Weighted-average common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
| Net loss from continuing operations per common share: | |||||
| Basic | |||||
| Diluted | |||||
| Net loss from discontinued operations per common share: | |||||
| Basic | |||||
| Diluted | |||||
| Net loss per common share: | |||||
| Basic | |||||
| Diluted |
Loading...